Cardiac failure has a principal underlying aetiology of ischaemic damage arising from vascular insufficiency. Molecules that regulate collateral growth in the ischaemic heart also regulate coronary vasculature formation during embryogenesis. Here we identify thymosin beta4 (Tbeta4) as essential for all aspects of coronary vessel development in mice, and demonstrate that Tbeta4 stimulates significant outgrowth from quiescent adult epicardial explants, restoring pluripotency and triggering differentiation of fibroblasts, smooth muscle cells and endothelial cells. Tbeta4 knockdown in the heart is accompanied by significant reduction in the pro-angiogenic cleavage product N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP). Although injection of AcS...
Background: Prior studies show that signature phenotypes of diabetic human induced pluripotent stem ...
The last 20 years witnessed the emergence of the thymosin 4 (T4)-N-acetyl-seryl-aspartyl-lysyl-proli...
Efficient cardiac regeneration postinfarction (MI) requires the replacement of lost cardiomyocytes, ...
Ischemic heart disease complicated by coronary artery occlusion causes myocardial infarction (MI), w...
The inability of the human heart to effectively repair itself after acute ischaemic injury has drive...
AbstractMyocardial infarction (MI) is one of the leading causes of morbidity and mortality world-wid...
Advances in pharmacological and interventional strategies for the treatment of ischaemic heart disea...
Induced pluripotent stem cells (iPSC) constitute a powerful tool to study cardiac physiology and rep...
The inability of the human heart to effectively repair itself after acute ischaemic injury has drive...
Cardiovascular disease remains the major cause of mortality, and cardiac cell therapy has recently e...
The epicardium has, like the other cell lineages of the terminally differentiated adult heart, long ...
Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newl...
Thymosin beta 4 (T beta 4) is a key factor in cardiac development, growth, disease, epicardial integ...
While cardiovascular diseases remain the major worldwide cause of mortality and morbidity, there is ...
Background—Prolonged myocardial ischemia results in cardiomyocyte loss despite successful revascular...
Background: Prior studies show that signature phenotypes of diabetic human induced pluripotent stem ...
The last 20 years witnessed the emergence of the thymosin 4 (T4)-N-acetyl-seryl-aspartyl-lysyl-proli...
Efficient cardiac regeneration postinfarction (MI) requires the replacement of lost cardiomyocytes, ...
Ischemic heart disease complicated by coronary artery occlusion causes myocardial infarction (MI), w...
The inability of the human heart to effectively repair itself after acute ischaemic injury has drive...
AbstractMyocardial infarction (MI) is one of the leading causes of morbidity and mortality world-wid...
Advances in pharmacological and interventional strategies for the treatment of ischaemic heart disea...
Induced pluripotent stem cells (iPSC) constitute a powerful tool to study cardiac physiology and rep...
The inability of the human heart to effectively repair itself after acute ischaemic injury has drive...
Cardiovascular disease remains the major cause of mortality, and cardiac cell therapy has recently e...
The epicardium has, like the other cell lineages of the terminally differentiated adult heart, long ...
Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newl...
Thymosin beta 4 (T beta 4) is a key factor in cardiac development, growth, disease, epicardial integ...
While cardiovascular diseases remain the major worldwide cause of mortality and morbidity, there is ...
Background—Prolonged myocardial ischemia results in cardiomyocyte loss despite successful revascular...
Background: Prior studies show that signature phenotypes of diabetic human induced pluripotent stem ...
The last 20 years witnessed the emergence of the thymosin 4 (T4)-N-acetyl-seryl-aspartyl-lysyl-proli...
Efficient cardiac regeneration postinfarction (MI) requires the replacement of lost cardiomyocytes, ...